SCHEMBL741197

SCHEMBL741197

CC(C)(NC(=O)c1cc2c(NC(=O)c3ccc(Cn4cccn4)cc3)n[nH]c2s1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.55
BCR P11274 2/20 0.55
AURKA O14965 4/20 0.48
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
TNIK Q9UKE5 1/20 0.41
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
LMNA P02545 2/20 0.40
HPGD P15428 2/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
SNCA P37840 1/20 0.39
CDC7 O00311 6/20 0.39
DAPK3 O43293 6/20 0.39
PAK4 O96013 6/20 0.39
CSNK1A1 P48729 6/20 0.39
CLK2 P49760 6/20 0.39
PRKX P51817 6/20 0.39
CDK5 Q00535 6/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL742531 0.87 ABL1 (0.54) ABL1BCRAURKATNIKSNCA
SCHEMBL4633253 0.86 HDAC1 (0.51) ABL1BCRAURKAHDAC1HDAC6
SCHEMBL742638 0.85 ABL1 (0.74) ABL1BCRAURKAHDAC1MAPT
SCHEMBL740623 0.85 ABL1 (0.72) ABL1BCRAURKAHDAC1TNIK
SCHEMBL743719 0.85 ABL1 (0.55) ABL1BCRAURKAHDAC1HDAC6
SCHEMBL741183 0.85 ABL1 (0.76) ABL1BCRAURKAHDAC1MAPT
SCHEMBL740752 0.85 ABL1 (0.76) ABL1BCRAURKAHDAC1MAPT
SCHEMBL739604 0.85 ABL1 (0.66) ABL1BCRAURKAHDAC1HDAC6
SCHEMBL740292 0.84 AURKA (0.55) ABL1BCRAURKAHDAC6KMT2A
SCHEMBL743125 0.84 ABL1 (0.65) ABL1BCRAURKAHDAC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed